Handling Missing Data in Within-Trial Cost-Effectiveness Ana…
Established
55
Citations212
Refs2017
Year
Search Works
Work Details
- DOI 10.1007/s41669-017-0015-6
- PMID https://pubmed.ncbi.nlm.nih.gov/29442336
- PMCID https://www.ncbi.nlm.nih.gov/pmc/articles/5691848
- OpenAlex ID W2586893366
- Type Review
- Language EN
- Published 09 Feb 2017
- Volume 1 (2)
- Pages 79–97
- Source PharmacoEconomics - Open
- Publisher Adis, Springer Healthcare
- FWCI 1.63
- Countries 1
- Institutions 2
- Added 17 Feb 2017
- Updated 28 Oct 2026
External Links
MENU
0
Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations
Review 2017 EN Gold
Cost-effectiveness analyses (CEAs) alongside randomised controlled trials (RCTs) are increasingly designed to collect resource use and preference-based health status data for the purpose of healthcare technology assessment. However, because of the way these measures are collected, they are prone to missing data, which can ultimately affect the decision of whether an intervention is good value for…
55
Citations
212
References
3
Authors
1.63
FWCI
Citations by Year
Last 10 yearsTopics
Keywords
Authors & Affiliations
3 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Andrea Gabrio Corresponding | University College London (GB) | |
| 2 | Alexina J. Mason | London School of Hygiene & Tro… (GB) | |
| 3 | Gianluca Baio | University College London (GB) |
Related Works
10Data: OpenAlex